ARTICLE | Distillery Therapeutics
Therapeutics: Myotubularin related protein 3 (MTMR3)
September 3, 2015 7:00 AM UTC
In vitro studies suggest inhibiting MTMR3 could help treat IBD in patients who harbor the rs713875 risk variant. In primary human monocyte-derived macrophages, a bacterial peptidoglycan recognized by ...